Corteva (CTVA) Projected to Release Earnings on Thursday

Corteva (NYSE:CTVA) is anticipated to release its Q2 2026 results after the market closes on Thursday, July 30th. Analysts expect Corteva to announce earnings of $2.23 per share and revenue of $6.5993 billion for the quarter. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Interested persons may review the information on the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Friday, July 31, 2026 at 9:00 AM ET.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.32. The company had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.13 earnings per share. On average, analysts expect Corteva to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Corteva Stock Performance

Shares of CTVA stock opened at $87.67 on Tuesday. The stock has a market capitalization of $58.64 billion, a P/E ratio of 51.57, a PEG ratio of 2.70 and a beta of 0.56. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. The firm’s 50 day moving average is $81.52 and its 200 day moving average is $79.12. Corteva has a 12 month low of $60.53 and a 12 month high of $89.39.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. Corteva’s payout ratio is presently 42.35%.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. State Street Corp boosted its stake in Corteva by 3.7% during the fourth quarter. State Street Corp now owns 36,570,876 shares of the company’s stock valued at $2,451,346,000 after buying an additional 1,290,071 shares during the period. Harris Associates L P grew its position in Corteva by 168.1% during the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock worth $1,141,268,000 after buying an additional 10,675,052 shares in the last quarter. Northern Trust Corp increased its stake in Corteva by 5.0% in the 4th quarter. Northern Trust Corp now owns 11,731,834 shares of the company’s stock worth $786,385,000 after acquiring an additional 562,550 shares during the last quarter. Invesco Ltd. raised its holdings in shares of Corteva by 16.7% in the 4th quarter. Invesco Ltd. now owns 11,404,960 shares of the company’s stock valued at $764,474,000 after acquiring an additional 1,630,712 shares in the last quarter. Finally, Morgan Stanley boosted its position in shares of Corteva by 1.4% during the 4th quarter. Morgan Stanley now owns 8,931,814 shares of the company’s stock valued at $598,700,000 after acquiring an additional 122,308 shares during the last quarter. Institutional investors own 81.54% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on CTVA shares. Zacks Research upgraded Corteva from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 13th. Oppenheimer lifted their price target on Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a research report on Thursday, July 23rd. Royal Bank Of Canada boosted their price objective on Corteva from $97.00 to $103.00 and gave the company an “outperform” rating in a research note on Tuesday, July 21st. Bank of America increased their price objective on Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a report on Monday, July 20th. Finally, Morgan Stanley raised their target price on Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 28th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, Corteva has a consensus rating of “Moderate Buy” and a consensus price target of $90.19.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.